| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Garry P. Nolan | Q89180933 |
| P2093 | author name string | Harris G Fienberg | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum | Q24594356 | ||
| Non-Darwinian dynamics in therapy-induced cancer drug resistance | Q27324745 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations | Q29614275 | ||
| Control of stochasticity in eukaryotic gene expression | Q29615955 | ||
| Causal protein-signaling networks derived from multiparameter single-cell data | Q29619136 | ||
| Intra-tumour heterogeneity: a looking glass for cancer? | Q29620149 | ||
| Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging | Q30544925 | ||
| viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia | Q30628090 | ||
| Quantitative analysis of pathways controlling extrinsic apoptosis in single cells | Q33807797 | ||
| Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities | Q33932561 | ||
| Functional and phylogenetic diversity as predictors of biodiversity--ecosystem-function relationships | Q34014811 | ||
| Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. | Q34274373 | ||
| Measuring and modeling apoptosis in single cells | Q34921455 | ||
| mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling | Q35581650 | ||
| On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics | Q35853714 | ||
| Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer | Q35895370 | ||
| Cell-to-cell variability in PI3K protein level regulates PI3K-AKT pathway activity in cell populations | Q36088956 | ||
| Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes | Q37003894 | ||
| Characterizing heterogeneous cellular responses to perturbations | Q37039523 | ||
| Large-scale proteomics analysis of the human kinome | Q37258113 | ||
| The TRAIL apoptotic pathway in cancer onset, progression and therapy | Q37278043 | ||
| Is TRAIL the holy grail of cancer therapy? | Q37385890 | ||
| Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. | Q39585980 | ||
| Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis | Q39861453 | ||
| Dynamic proteomics of individual cancer cells in response to a drug. | Q39913838 | ||
| Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells | Q39933573 | ||
| Regulated noise in the epigenetic landscape of development and disease | Q41514448 | ||
| Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase | Q44381498 | ||
| Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway | Q44389071 | ||
| PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. | Q44559505 | ||
| Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events | Q44593406 | ||
| Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. | Q52652438 | ||
| Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours. | Q53311592 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85-94 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Mass cytometry to decipher the mechanism of nongenetic drug resistance in cancer | |
| P478 | volume | 377 |
Search more.